BMW's Autumn Tightrope: Can Cost Cuts and the i3 Outweigh China's Drag and a Recall Spree?

BMW shares hover near yearly low after Q2 net profit drops 35% amid China sales decline; cost cuts and Neue Klasse launch aim to stabilize margins.

BMW's share price is hovering dangerously close to its 52-week floor, and the pressure comes from two directions at once. The stock closed recently at €58.64, roughly 4 percent above the yearly low of €56.40 hit on July 24, while the second-quarter earnings report—released on August 14—confirmed just how deep the automaker's profit slump has become. For investors, the question is no longer whether BMW is in trouble, but whether the company's planned remedies can take hold before the situation deteriorates further.

The numbers from the second quarter paint a stark picture. Net profit tumbled roughly 35 percent to €1.2 billion, while operating profit in the automotive segment plunged 60 percent to €629 million. Revenue slipped from €34 billion to €31.26 billion, a decline of 7.86 percent, with earnings per share coming in at €2.05 against €2.85 in the same period a year earlier. The culprit is well known: BMW's once-lucrative Chinese market is eroding fast. Second-quarter deliveries there fell to just 117,815 vehicles, a 30.2 percent drop year-on-year, bringing the first-half decline to 20.4 percent.

The June 16 profit warning had already reset expectations, slashing the EBIT margin forecast for the automotive segment to between 1 and 3 percent. Now the market is watching to see whether the cost-cutting program can stabilize that margin while China continues to shrink. CFO Walter Mertl has earmarked around €1 billion for personnel measures, with a three-digit million amount expected to hit this year's books. The plan calls for roughly 8,000 job cuts by 2027, more than half of them in Germany, via a voluntary severance program slated to begin in October—all without compulsory redundancies.

Complicating matters, BMW has been dealing with a string of technical recalls that, while routine in isolation, are landing at an awkward moment. The most recent covers 5 Series, 7 Series, and 8 Series sedans over a parking brake defect that could allow vehicles to roll away unintentionally. A worldwide recall of the S 1000 RR motorcycle over engine, ABS, and lighting issues has also added to the noise. For a company of BMW's scale, recall costs are typically manageable—the real concern is whether they signal deeper quality problems that could dent confidence in core model lines during a pivotal strategic transition.

That transition is centered on the Neue Klasse architecture and the production launch of the fully electric i3 sedan at the Munich plant. The first i3s are already rolling off the line, with European customer deliveries expected to begin this autumn. The BEV segment showed some resilience in the second quarter, with deliveries up 5.2 percent to 116,807 units, and the iX3 is on track for 100,000 orders. BMW is also repositioning the ALPINA brand as an exclusive luxury segment, which could open additional revenue streams.

There are other glimmers of optimism. Dorothea von Boxberg, formerly CFO of Lufthansa Cargo and CEO of Brussels Airlines, takes over the personnel, labor, and real estate portfolio on September 1—bringing turnaround experience from another capital-intensive business. An insider purchase by board member Milan Nedeljkovi? in May, roughly 5,200 shares at just over €76, could be read as a confidence signal, though the stock has since fallen well below that level. HSBC upgraded the shares from Hold to Buy on July 16, albeit while cutting its price target from €79 to €71—an acknowledgment of valuation opportunity rather than an endorsement of operational recovery.

The bear case, however, is substantial. Bernstein Research slashed its price target in June from €108 to €85 on revised revenue, EBIT, and cash flow forecasts, while maintaining an Outperform rating. More recently, RBC Capital Markets cut its target from €62 to €60 on August 14, keeping a Sector Perform rating—just a couple of euros above the current share price. RBC cited China's weak demand and intense European competition as structural issues that no single recall can explain. The stock sits roughly 2 percent below its 50-day moving average, suggesting near-term momentum remains negative.

Adding to the structural concerns, media reports suggest the agency model rollout in Germany has been delayed again, now expected no earlier than July 2028—another sign that internal adjustments are moving more slowly than planned. If Chinese demand keeps sliding while cost savings only materialize in the medium term, the margin could remain stuck at the lower end of the 1-to-3 percent band.

The immediate catalysts are clear. The voluntary severance program's October launch will test whether the cost reductions arrive quickly enough to cushion the earnings decline. The autumn i3 deliveries in Europe will show whether the new model can generate meaningful volume. Until then, the automotive margin remains the key gauge—and the stock's fate hinges on whether the cost program can support the share price or merely slow its descent. Should the share hold above €56.40 without another profit warning, the market may treat the current level as a base. A further drop in China sales or a delay in the severance program, however, could send the stock back toward its yearly low.